169 related articles for article (PubMed ID: 32598763)
1. [The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications].
Ostroumova OD; Kochetkov AI; Pereverzev AP; Kravchenko EV; Kazjulin AN; Andreev DN; Pavleeva EE
Ter Arkh; 2019 Aug; 91(8):118-126. PubMed ID: 32598763
[TBL] [Abstract][Full Text] [Related]
2. Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012 - 2016).
Bundhun PK; Teeluck AR; Bhurtu A; Huang WQ
BMC Cardiovasc Disord; 2017 Jan; 17(1):3. PubMed ID: 28056809
[TBL] [Abstract][Full Text] [Related]
3. Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review.
Sherwood MW; Melloni C; Jones WS; Washam JB; Hasselblad V; Dolor RJ
J Am Heart Assoc; 2015 Oct; 4(11):. PubMed ID: 26514161
[TBL] [Abstract][Full Text] [Related]
4. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
Tran M; Tafreshi J; Pai RG
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors and potential interactions with clopidogrel: an update.
Gerson LB
Curr Gastroenterol Rep; 2013 Jun; 15(6):329. PubMed ID: 23695547
[TBL] [Abstract][Full Text] [Related]
6. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
Kwok CS; Jeevanantham V; Dawn B; Loke YK
Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
[TBL] [Abstract][Full Text] [Related]
7. Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis.
Biswas M; Rahaman S; Biswas TK; Ibrahim B
Int J Clin Pharm; 2021 Oct; 43(5):1360-1369. PubMed ID: 33774763
[TBL] [Abstract][Full Text] [Related]
8. Concomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome- a systematic review.
Focks JJ; Brouwer MA; van Oijen MG; Lanas A; Bhatt DL; Verheugt FW
Heart; 2013 Apr; 99(8):520-7. PubMed ID: 22851683
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents.
Farhat N; Fortin Y; Haddad N; Birkett N; Mattison DR; Momoli F; Wu Wen S; Krewski D
Crit Rev Toxicol; 2019 Mar; 49(3):215-261. PubMed ID: 31192763
[TBL] [Abstract][Full Text] [Related]
10. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel and proton pump inhibitors: is there a significant drug-drug interaction?
Shmulevich E; Friger M; Gilutz H; Azab AN
Can J Cardiovasc Nurs; 2011; 21(4):27-36. PubMed ID: 22165503
[TBL] [Abstract][Full Text] [Related]
12. [Coronary stent thrombosis in concurrent clopidogrel and proton pump inhibitor therapy].
Juel J; Jensen SE
Ugeskr Laeger; 2011 Feb; 173(9):654-8. PubMed ID: 21362394
[TBL] [Abstract][Full Text] [Related]
13. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.
Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ
Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094
[TBL] [Abstract][Full Text] [Related]
14. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.
Charlot M; Ahlehoff O; Norgaard ML; Jørgensen CH; Sørensen R; Abildstrøm SZ; Hansen PR; Madsen JK; Køber L; Torp-Pedersen C; Gislason G
Ann Intern Med; 2010 Sep; 153(6):378-86. PubMed ID: 20855802
[TBL] [Abstract][Full Text] [Related]
15. Adverse cardiovascular effects of concomitant use of proton pump inhibitors and clopidogrel in patients with coronary artery disease: a systematic review and meta-analysis.
Huang B; Huang Y; Li Y; Yao H; Jing X; Huang H; Li J
Arch Med Res; 2012 Apr; 43(3):212-24. PubMed ID: 22564422
[TBL] [Abstract][Full Text] [Related]
16. Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
Burkard T; Kaiser CA; Brunner-La Rocca H; Osswald S; Pfisterer ME; Jeger RV;
J Intern Med; 2012 Mar; 271(3):257-63. PubMed ID: 21726302
[TBL] [Abstract][Full Text] [Related]
17. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel with proton pump inhibitors: safe or not?
Mehta A; Mehta D; Loganathan J; Paladugu N; Bhalodkar NC
Clin Cardiol; 2011 Sep; 34(9):528-31. PubMed ID: 21717475
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.
Kwok CS; Loke YK
Aliment Pharmacol Ther; 2010 Apr; 31(8):810-23. PubMed ID: 20102352
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
Lettino M
Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
